Pfizer Stops Enrollment In COVID-Pill Trial After Latest Lousy Results
“Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid - its COVID-19 antiviral pill - for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree.”
Read moreCDC Director Issues Alert On Pfizer's COVID-19 Pill
““If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday.”
Read moreDid Pfizer Know that Paxlovid will NOT Work in the Vaccinated?
“What made Pfizer change this criterion? My speculative answer is that Pfizer knew that Paxlovid did not work in the vaccinated. Having failed to hit the target when it came to vaccinated people, Pfizer decided to remove them from the trial and “move the target,” so to speak. This way, the EPIC-SR study would end up being a “success,” technically.”
Read moreEight things you need to know about Pfizer’s new COVID pill
“Pharmaceutical giant Pfizer Inc. Friday announced that its “game-changer” pill to treat COVID-19 had “overwhelming efficacy” in clinical trials. The company plans to request approval for the pill (an oral antiviral drug it named Paxlovid) from the Food and Drug Administration (FDA) before Thanksgiving on November 25th.”
Read more